The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2022

Filed:

Mar. 14, 2018
Applicant:

Chr. Hansen A/s, Hoersholm, DK;

Inventors:

Dorthe Sandvang, Slangerup, DK;

Tina Styrishave, Ringsted, DK;

Assignee:

CHR. HANSEN A/S, Hoersholm, DK;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A23K 1/17 (2006.01); A23K 1/165 (2006.01); A23K 1/18 (2006.01); A61K 47/00 (2006.01); A61K 45/00 (2006.01); A01N 63/00 (2020.01); A61K 39/108 (2006.01); A61K 39/08 (2006.01); A61K 35/742 (2015.01); A23K 50/75 (2016.01); A23K 10/18 (2016.01); A61K 9/00 (2006.01); C12N 1/20 (2006.01); C12R 1/125 (2006.01);
U.S. Cl.
CPC ...
A61K 35/742 (2013.01); A23K 10/18 (2016.05); A23K 50/75 (2016.05); A61K 9/0053 (2013.01); C12N 1/205 (2021.05); A01N 63/00 (2013.01); C12R 2001/125 (2021.05);
Abstract

The present invention provides astrain selected from the group consisting of a) the strain deposited as DSM32324, b) the strain deposited as DSM32325, and c) a mutant strain of (a) or (b) which has sensitivity for ampicillin, vancomycin, gentamicin, kanamycin, streptomycin, erythromycin, clindamycin, tetracycline, and chloramphenicol; and has inhibitory activity againstand. The invention further relates tocompositions comprising at least onestrain of the invention, preferably thestrain DSM32324 and/or thestrain DSM32325, as Direct Fed Microbial (DFM), premix, animal feed additive or animal feed. The invention provides a method of improving one or more animal performance parameters selected from the group consisting of i) increased weight gain (WG), ii) lower feed conversion ratio (FCR), iii) lower necrotic enteritis lesion scoring, iv) lower necrotic enteritis frequency, v) lower necrotic enteritis mortality, vi) increased European Production Efficacy Factor (EPEF), and vii) lower mortality, by feeding a strain or a composition according to the invention to an animal.


Find Patent Forward Citations

Loading…